Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 22, 2025
Made in America: Inovair High-Efficiency Blowers Are the First to Meet BABA Requirements
GlobeNewswire
·
May 22, 2025
Lenexa, Kansas , May 22, 2025 (GLOBE NEWSWIRE) -- Building on over 30 years of innovation and manufacturing excellence, Inovair has been recognized by EPA as the first and only manufacturer of high-efficiency blower packages that are fully compliant with …
VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING
GlobeNewswire
·
May 22, 2025
Dallas, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 26, 2025 to stockholders of …
KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life
GlobeNewswire
·
May 22, 2025
GUADALAJARA, Mexico, May 22, 2025 (GLOBE NEWSWIRE) -- The countdown has begun, KMBIO an P2P exchange focusing on LATAM market has officially opened its private sale round as part of its fundraising campaign. In the midst of the global expansion of digital …
GENFIT Reports First Quarter 2025 Financial Information
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver …
GENFIT : Information financière du premier trimestre 2025
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du …
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
GlobeNewswire
·
May 22, 2025
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 …
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Rapid7 to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 22, 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models …
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 22, 2025
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 …
Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire
·
May 22, 2025
SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its …
Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 22, 2025
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR) rate of 71% (5/7 patients) – …
Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
·
May 22, 2025
ISELIN, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced an …
Intchains Group Limited Reports First Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
May 22, 2025
Total revenues of US$18.2 million exceeds guidance, up 445.5% YoY Total ETH-based cryptocurrency units were approximately 7,023, up 23.2% QoQ Income from operations reach US$5.1 million, achieving turnaround from prior-year period SINGAPORE, May 22, 2025 ( …
Gyre Therapeutics’ Hydronidone Met the Primary Endpoint and Demonstrated Statistically Significant Fibrosis Regression in Pivotal Phase 3 Trial for the Treatment of CHB-associated Liver Fibrosis in China
GlobeNewswire
·
May 22, 2025
Achieved statistically significant ≥1-stage fibrosis regression at Week 52 vs. placebo (52.85% vs. 29.84%, P=0.0002). Demonstrated favorable safety and tolerability profile: 4.88% serious adverse events vs. 6.45% for placebo; zero discontinuations due to …
Lakeland Fire + Safety to Attend the 6th Annual CEO Networking Event Hosted by Semco Capital
GlobeNewswire
·
May 22, 2025
HUNTSVILLE, Ala., May 22, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today …
IPG Photonics Appoints Mira Sahney as Senior Vice President of Global Laser Systems
GlobeNewswire
·
May 22, 2025
MARLBOROUGH, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in high-performance fiber lasers and laser systems, announced the appointment of Mira Sahney as Senior Vice President, Global Laser Systems. …
Skywork.ai Launches Globally, Introducing the World’s First DeepResearch-Powered Workspace Super Agents
GlobeNewswire
·
May 22, 2025
Singapore , May 22, 2025 (GLOBE NEWSWIRE) -- In May 2025, Skywork.ai officially entered the global stage, launching the world’s first AI Office Suite powered by DeepResearch technology, with full support for both English and Japanese to enhance …
PESG Research Report: A Review of Silexion Therapeutics' Innovative KRAS-Driven Cancer Treatment
GlobeNewswire
·
May 22, 2025
New York, May 22, 2025 (GLOBE NEWSWIRE) -- PESG Research today announced the release of a report examining Silexion Therapeutics, an innovative biotechnology company developing unique RNA interference (RNAi) therapies targeting KRAS-driven cancers. The …
Toll Brothers Apartment Living® and Canyon Partners Real Estate Announce the Grand Opening of Navona, a New Luxury Apartment Community in Mesa, Arizona
GlobeNewswire
·
May 22, 2025
MESA, Ariz., May 22, 2025 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living®, the rental subsidiary of Toll Brothers, Inc. (NYSE: TOL), the nation's leading builder of luxury homes, in partnership with Canyon Partners Real Estate, announces the grand …